Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Hutterer, Georg C; Posch, Florian; Buser, Lorenz; Zigeuner, Richard; Morshäuser, Laura; Otto, Wolfgang; Wild, Peter J; Burger, Maximilian; May, Matthias; Pichler, Martin; Brookman-May, Sabine D (2019). BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study. Urologic oncology, 37(7):510-518.

Morshaeuser, Laura; May, Matthias; Burger, Maximilian; Otto, Wolfgang; Hutterer, Georg C; Pichler, Martin; Klatte, Tobias; Wild, Peter; Buser, Lorenz; Brookman-May, Sabine (2018). p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urologic oncology, 36(3):94.e15-94.e21.

Weyerer, Veronika; Schneckenpointner, Roland; Filbeck, Thomas; Burger, Maximilian; Hofstaedter, Ferdinand; Wild, Peter J; Fine, Samson W; Humphrey, Peter A; Dehner, Louis P; Amin, Mahul B; Rüschoff, Josef; Boltze, Carsten; Tannapfel, Andrea; Zwarthoff, Ellen; Lopez-Beltran, Antonio; Montironi, Rodolfo; Langner, Cord; Stoehr, Robert; Hartmann, Arndt; Giedl, Johannes (2017). Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years. Journal of Cancer, 8(3):1-9.

Poyet, Cédric; Hermanns, Thomas; Zhong, Qing; Drescher, Eva; Eberli, Daniel; Burger, Maximilian; Hofstaedter, Ferdinand; Hartmann, Arndt; Stöhr, Robert; Zwarthoff, Ellen; Sulser, Tullio; Wild, Peter (2015). Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer. Oncology Letters, 10(5):2753-2760.

This list was generated on Thu Sep 19 00:54:11 2019 CEST.